U-IGMS

Q:IGMS - IGM BIOSCIENCES INC - https://www.igamesentertainment.com

17:22:19 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
IGMS - Q	2.0	1.31	·	1.36	0.7	1.35	-0.01	-0.7	481.6	618	614	1.35 1.365 1.35	22.50 0.92	16:29:37	Jul 03	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market: Nasdaq -- Bid Tick: Down -- UPC Restricted: No
Financial Status: Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Options · Portfolio

Recent Trades - Last 10 of 614

More trades...

Time ET	Ex	Price	Change	Volume
16:29:37	Q	1.3403	-0.0197	5
16:04:05	Q	1.35	-0.01	1
16:00:01	Q	1.35	-0.01	115
16:00:01	Q	1.35	-0.01	3
16:00:01	Q	1.35	-0.01	200
16:00:01	Q	1.35	-0.01	151
16:00:01	Q	1.35	-0.01	1
16:00:01	Q	1.35	-0.01	563
16:00:01	Q	1.35	-0.01	3
16:00:00	Q	1.35	-0.01	200

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2025-07-03 17:29	U:IGMS	News Release200	$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: GMS, IGMS, MRC, and GRYP
2025-07-01 08:59	U:IGMS	News Release200	IGM Biosciences Enters into Agreement to Be Acquired by Concentra Biosciences for $1.247 in Cash per Share Plus a Contingent Value Right
2025-01-09 13:00	U:IGMS	News Release200	IGM Biosciences Provides Strategic Update on Autoimmunity Pipeline Programs
2024-11-08 07:00	U:IGMS	News Release200	IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update
2024-11-04 07:00	U:IGMS	News Release200	IGM Biosciences to Present at Three Upcoming Investor Conferences
2024-09-30 16:01	U:IGMS	News Release200	IGM Biosciences Announces Strategic Pivot to Focus Exclusively on Autoimmunity
2024-09-10 16:05	U:IGMS	News Release200	IGM Biosciences to Present at the Stifel 2024 Virtual Immunology and Inflammation Summit
2024-08-14 07:00	U:IGMS	News Release200	IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate Update

Date ET

Symbol

Type

Headline

2025-07-03 17:29

U:IGMS

News Release

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: GMS, IGMS, MRC, and GRYP

2025-07-01 08:59

U:IGMS

News Release

IGM Biosciences Enters into Agreement to Be Acquired by Concentra Biosciences for $1.247 in Cash per Share Plus a Contingent Value Right